Among the 20 scored health care organizations in Durham, Global Genomic Medicine Collaborative holds 2.8 months of operating reserves (peer median 6.3 months), runs a typical yearly deficit of 46.4% (peers: surplus of 4.7%), and has grown spending 9.3% a year (peers: grown spending 7.2% a year).
In fiscal year 2023 it reported $226,540 in revenue and $1,183,266 in expenses, with contributions making up 95.5% of revenue.
Peers: the 20 Durham health care organizations with a score, ranked or below the bar.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$226,540Fiscal year 2023
Expenses$1,183,266Fiscal year 2023
Total assets$279,746Fiscal year 2023
Total liabilities$2,985Fiscal year 2023
Fiscal year ending December2023
Revenue$226,540
Expenses$1,183,266
Net income−$956,726
Net assets$276,761
Notable sources of revenue
Percent of total revenue
Contributions
$216,414
95.5%
Program services
$0
0.0%
Investment income
$9,388
4.1%
Other (net)
$738
0.3%
Assets / debt
Total assets
$279,746
Total liabilities
$2,985
Net assets
$276,761
Compensation
Officers and key employees
$0
Share of expenses
0.0%
Fiscal year ending December2022
Revenue$952,070
Expenses$1,082,162
Net income−$130,092
Net assets$1,233,487
Notable sources of revenue
Percent of total revenue
Contributions
$951,989
100.0%
Program services
$0
0.0%
Investment income
$81
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$1,234,362
Total liabilities
$875
Net assets
$1,233,487
Compensation
Officers and key employees
$0
Share of expenses
0.0%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?